How genetic testing works: from DNA to your report
A small sample can reveal information about inherited differences in your DNA. This guide follows the science from the sample to the report, and explains how to understand the results in the context of your health.
1. DNA, genes and genetic variants
DNA stores hereditary information using four chemical bases, abbreviated A, T, C and G. Their order forms a biological code. Genes are stretches of DNA involved in making functional molecules, including proteins. Most of our DNA is shared with other people; differences at particular positions help explain some of our individual characteristics.
A genetic variant is a difference in a DNA sequence. A common kind involves a single base and is called a single nucleotide polymorphism, or SNP. Many variants have no known harmful effect. Some influence traits, some are associated with disease risk, and others still have an uncertain meaning. Finding a difference does not automatically mean finding a disease.
2. How a sample becomes a report
For many at-home tests, saliva or a cheek swab provides cells containing DNA. The laboratory extracts the DNA and analyses the genetic information covered by the test. The collection method does not, on its own, tell you how much of the genome will be examined.
The laboratory data then need interpretation. Detected variants are compared with scientific evidence or reference datasets to produce the relevant results. The report you receive is therefore a combination of measurement and interpretation: the technology determines what is examined, while the evidence determines what can be said about it.
3. Gene chips and sequencing read DNA differently
A genotyping chip uses many small DNA probes to examine selected positions across the genome. You can think of it as checking a prepared list of addresses. It can examine many variants at once, but it does not read every letter of your DNA. A result applies to the positions and variant types the test is designed to detect.
Sequencing determines the order of DNA bases in the regions being tested. A targeted panel examines selected genes or regions; whole-exome sequencing focuses mainly on protein-coding regions; whole-genome sequencing examines DNA much more broadly. Broader coverage can reveal more variation, but not every finding has a clear medical meaning.
The number of report topics is not the same as the number of genes or variants tested. To compare products, look at the testing method, the regions covered and the question the test is intended to answer.
4. Genetic risk is a probability, not a certainty
Some conditions are strongly influenced by a variant in a single gene. Many common conditions involve numerous genetic differences together with age, environment and lifestyle. A polygenic risk score combines information from multiple variants into a statistical estimate; on its own, it does not include all the other influences on your health.
An association found in a population does not prove that a particular person will develop a condition. A higher-risk result is not a diagnosis, and a lower-risk result is not a guarantee of protection. Interpretation also depends on how well the evidence represents people with a similar genetic background.
Relative risk and absolute risk answer different questions. As a purely illustrative example, twice a baseline risk of 1% would be 2%, not 100%. This is arithmetic to explain the terms, not a personal risk calculation or a result for any disease or product.
5. What different report topics mean
Ancestry estimates compare patterns in your DNA with reference populations. The estimates depend on the database and analysis method, so different services may give different answers. Results may also change as reference data grow. They describe genetic similarities, rather than defining your nationality or cultural identity.
Trait reports explore associations with characteristics such as taste or other inherited tendencies. Complex traits also reflect non-genetic influences. A nutrition, skin or fitness topic does not, by itself, establish a deficiency, skin diagnosis or ideal training plan. The strength of evidence differs between topics.
Health-risk reports concern susceptibility to specified conditions. Pharmacogenetic reports concern genetic influences on the way the body processes or responds to certain medicines. Discuss medication findings with your prescriber or pharmacist; do not start, stop or change a dose on the basis of a consumer report.
6. Read the result together with its scope
For a test looking for disease-related variants, a negative result means none of the reportable variants covered by that test were found. It does not exclude variants outside its scope or rule out every cause of disease. An uncertain result means that the available evidence cannot yet explain a finding reliably; it should not be treated as a confirmed cause.
For a result that may affect medical care, a clinician or genetic counsellor can review the original report, your symptoms and family history, and decide whether clinical confirmation is needed. Keep routine screening and medical follow-up based on your healthcare professional’s advice.
7. Consumer and clinical tests have different purposes
Consumer testing can help you explore ancestry, traits and selected genetic risks. Clinical genetic testing is selected to investigate a medical question and may help establish a diagnosis, assess inherited risk or guide care. The same type of sample or technology can be used in different settings, so the intended use and interpretation matter as well as the method.
If you are exploring testing because of symptoms, a known family condition or a treatment decision, start with a clinical assessment. If you want to understand the consumer products shown here, you can next explore their report topics and watch the sample collection guide.
Common questions · 4
Does a saliva test read my whole genome?
Not necessarily. Saliva is a way to collect DNA. Whether the test checks selected variants, selected genes or broader regions depends on the laboratory method and product scope.
Can a consumer cancer-risk report diagnose cancer?
No. Inherited susceptibility is different from detecting an existing tumour. Symptoms and cancer-screening decisions need medical assessment, regardless of whether a consumer result is higher or lower risk.
Why might two reports give different results?
They may examine different variants or use different reference datasets, statistical models or evidence updates. Compare the same question and testing scope before treating the results as contradictory.
Does a high-risk result mean my relatives have it too?
No. Relatives share some genetic information, but can inherit different combinations of variants. If a finding suggests a clinically important inherited condition, a genetics professional can advise whether family testing would be useful.
Explore your next step
This article explains genetic testing and does not provide a personal diagnosis or treatment advice. Discuss health and medication findings with a clinician or genetics professional.